Tiziana Life Sciences Ltd
Research Tiziana Life Sciences Ltd (TLSA) on Bullrun: market cap USD 156.53M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTLSA
- ExchangeNASDAQ
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 156.53M
- Financial periodFY2024
- Net income-USD 11.86M
- Free cash flow-USD 1.55M
Valuation Snapshot
latest market cap is USD 156.53M.
About Tiziana Life Sciences Ltd
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis;
Frequently asked questions
What is Tiziana Life Sciences Ltd's market cap?
Tiziana Life Sciences Ltd's market capitalization is USD 156.53M.
What does Tiziana Life Sciences Ltd do?
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally.